Tuesday, May 26, 2020 2:48:16 PM
Item 5.07 Submission of Matters to a Vote of Security Holders.
By notice dated June 8, 2012, the Company called an Annual Meeting of Shareholders of the Company to be held on June 29, 2012. Shareholders of record as of June 5, 2012 were entitled to notice of, and to vote at, the meeting.
Under Georgia law and the Company’s bylaws, a quorum must be present in order for any action to be taken at the meeting. The presence of a majority of the Company’s outstanding shares constitutes a quorum. As of the record date, there were 231,299,810 shares of stock outstanding. The Company determined that only 78,494,028 shares were represented in person or by proxy at the meeting. Accordingly, a quorum was not present at the meeting and no action could be taken.
As a quorum was not present, no votes were cast at the meeting. The Company did receive proxies or ballots directing that their shares be voted as follows (although no votes were cast):
Votes Votes Broker/
For Withhold Non-Votes
Maher Albitar, M.D. 66,982,426 11,511,602 0
Curtis G. Anderson 76,195,324 2,298,704 0
Stephen D. Barnhill, M.D. 29,394,877_____ 49,099,151 0
Herbert A. Fritsche, Ph.D. 67,645,618 10,848,410 0
Joseph McKenzie, D.V.M. 75,747,942 2,746,086 0
As a result, the Directors listed above will continue to serve until the election and qualification of their successors or until their earlier resignation.
For the annual meeting, the Company received proxies with respect to the election of directors representing 78,494,028 shares. This is consistent with the shareholders meeting held in October 2010, in which the Company received proxies representing 79,387,294 shares in the election of directors.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Stephen D. Barnhill, M.D.
Chairman and Chief Executive Officer
Recent HDVY News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 09:13:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 07:53:39 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM